Evaluation of Clinical and Endoscopic Parameters As Predictors for Neoplastic Progression in Barrett's Patients With a Diagnosis of Indefinite for Dysplasia

被引:0
|
作者
Horvath, Bela
Singh, Prabhdeep
Xie, Hao
Thota, Prashanthi N.
Liu, XiuLi
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1854
引用
收藏
页码:S312 / S313
页数:2
相关论文
共 50 条
  • [31] CLINICAL AND ENDOSCOPIC PREDICTORS OF NEOPLASTIC PROGRESSION IN BARRETT'S ESOPHAGUS SURVEILLANCE: A MULTI-CENTER COMMUNITY BASED PROSPECTIVE COHORT STUDY
    Klaver, Esther
    Gonzalez, Angela Bureo
    Mallant-Hent, Rosalie
    Baak, Lubbertus C.
    Bohmer, Clarisse
    van Oijen, Arnoud
    Naber, Anton H.
    Scholten, Pieter
    Duits, Lucas C.
    Bergman, Jacques
    Pouw, Roos E.
    GASTROENTEROLOGY, 2018, 154 (06) : S4 - S4
  • [32] Predictors for Neoplastic Progression in Patients with Barrett Esophagus: A Prospective Cohort Study
    Sikkema, Marjolein
    Kerkhof, Marjon
    Looman, Caspar W.
    Kuipers, Ernst J.
    Siersema, Peter D.
    GASTROENTEROLOGY, 2009, 136 (05) : A158 - A158
  • [33] Risk Factors for Predicting Neoplastic Progression in Patients With Barrett's Esophagus and Low-Grade Dysplasia
    Zavos, Christos
    Verbeek, Romy E.
    Leenders, Max
    Moons, Leon M.
    Vleggaar, Frank P.
    Siersema, Peter D.
    GASTROENTEROLOGY, 2013, 144 (05) : S675 - S676
  • [34] Mutational load may predict risk of progression in patients with Barrett's oesophagus and indefinite for dysplasia: a pilot study
    Trindade, Arvind J.
    McKinley, Matthew J.
    Alshelleh, Mohammad
    Levi, Gabriel
    Stewart, Molly
    Quinn, Kathy J.
    Thomas, Rebecca M.
    BMJ OPEN GASTROENTEROLOGY, 2019, 6 (01):
  • [35] RISK OF DYSPLASTIC PROGRESSION IN PATIENTS WITH BARRETT'S ESOPHAGUS INDEFINITE FOR DYSPLASIA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Henn, Andrew J.
    Moscoso, Carlos G.
    Hayat, Umar
    Bongiorno, Connie
    Sultan, Shahnaz
    Shaukat, Aasma
    Hanson, Brian J.
    GASTROENTEROLOGY, 2019, 156 (06) : S281 - S282
  • [36] Clinical significance and management of Barrett's esophagus with epithelial changes indefinite for dysplasia
    Prashanthi N Thota
    Gaurav Kistangari
    Ashwini K Esnakula
    David Hernandez Gonzalo
    Xiu-Li Liu
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2016, 7 (03) : 406 - 411
  • [37] EARLY HISTOLOGICAL PREDICTORS OF PROGRESSION IN PATIENTS WITH BARRETT'S ESOPHAGUS RELATED LOW GRADE DYSPLASIA
    Tsoi, Edward H.
    Williams, Richard
    Christie, Michael
    Cameron, Georgina
    Sundararajan, Vijaya
    Desmond, Paul V.
    Taylor, Andrew C.
    GASTROENTEROLOGY, 2018, 154 (06) : S898 - S898
  • [38] Persistent indefinite for dysplasia in Barrett's esophagus is a risk factor for dysplastic progression to low-grade dysplasia
    Henn, Andrew J.
    Song, Kevin Y.
    Gravely, Amy A.
    Mesa, Hector
    Sultan, Shahnaz
    Shaheen, Nicholas J.
    Shaukat, Aasma
    Hanson, Brian J.
    DISEASES OF THE ESOPHAGUS, 2020, 33 (09)
  • [39] Risk Stratification of Patients With Barrett's Esophagus and Low-grade Dysplasia or Indefinite for Dysplasia
    Thota, Prashanthi N.
    Lee, Hyun-Ju
    Goldblum, John R.
    Liu, Xiuli
    Sanaka, Madhusudhan R.
    Gohel, Tushar
    Kanadiya, Mehulkumar
    Lopez, Rocio
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (03) : 459 - 465
  • [40] Clinical and Endoscopic Differences Between Patients With Barrett's Esophagus With and Without Dysplasia/Adenocarcinoma
    Valdovinos-Andraca, Francisco
    Bartnicki-Navarrete, Isaac
    Bernal-Mendez, Ambrosio R.
    Barreto-Zuniga, Rafael Rafael
    Romano-Munive, Adriana F.
    Gamboa-Dominguez, Armando
    Elizondo-Rivera, Javier
    Briseno-Garcia, Daniel
    Tellez-Avila, Felix I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)